Bleeding Management İn Open Heart Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-84
SponsorSerkan Uckun

About this trial

This study aims to develop an algorithm that can guide targeted bleeding management through thromboelastography (TEG) viscoelastic testing performed on blood samples from patients undergoing open heart surgery. The goal is to develop an algorithm that supports targeted bleeding management based on TEG parameters. The study is prospective, in vitro, and non-invasive. The material will consist of residual blood samples from open heart surgery patients. Analyses will be performed using TEG parameters (R time, K time, MA, LY30). Patients will be randomized using a closed-envelope method and divided into two groups: anesthesiologist standard clinical observation-control (Group K) and anesthesiologist standard clinical observation and TEG analysis (Group T). The sample size is 70 patients per group. From an ethical standpoint, this study uses anonymous data without additional blood collection and ensures patient safety.

Eligibility criteria

Qualifiers

Patients who will undergo open heart surgery

Patients who have given informed consent

Disqualifiers

Patients undergoing emergency surgery

Patients with known congenital coagulation disorders

Patients with a known history of bleeding diathesis

Patients receiving uninterrupted anticoagulant therapy at an optimal time

Trial design

Treatments tested in this trial

  • Blood Product

Treatment groups

140 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Serkan Uckun

Lead sponsor

Balikesir University

Sponsor institution